FDA

Advertisement
Nov 14 2025HEALTH

The Peptide Trend: A Closer Look at the Hype and Risks

Peptides are short chains of amino acids that play crucial roles in the body. Insulin and GLP-1s are well-known examples, but many others remain unapproved by regulators. Despite this, they have become popular in the wellness world, with influencers and celebrities promoting them for various benefit

reading time less than a minute
Nov 13 2025HEALTH

FDA Speeds Up Approval for Rare Disease Treatments

The FDA has introduced a new approach to get treatments for rare genetic diseases to patients faster. Normally, drugs need to go through big, time-consuming studies. But now, for some serious conditions, smaller studies might be enough. This new method focuses on the science behind the treatment an

reading time less than a minute
Nov 12 2025HEALTH

New Leader Takes Charge at FDA's Drug Division

The FDA has picked Dr. Richard Pazdur to head up its drug division. He's been with the agency for 26 years and is well-respected. This move comes after a rough patch for the FDA, with lots of staff leaving and morale taking a hit. Dr. Pazdur is known for approving many new cancer drugs. These drugs

reading time less than a minute
Nov 12 2025HEALTH

Menopause and the Mixed Messages from Health Officials

The Department of Health and Human Services recently made a big announcement. They said that hormone replacement therapy (HRT) would no longer carry a severe warning. This warning had suggested that HRT could cause cancer and stroke. The FDA decided to remove this warning, saying it was based on out

reading time less than a minute
Nov 12 2025HEALTH

Baby Formula Recall: What's Happening and Why It Matters

A big recall is underway for ByHeart's organic baby formula. This comes after a number of babies got sick with infant botulism. The recall now covers all of their products, not just a few batches. Fifteen babies in twelve states have fallen ill since August. All of them were given ByHeart formula.

reading time less than a minute
Nov 12 2025HEALTH

A New Leader for Drug Regulation: What It Means for Us

The U. S. Food and Drug Administration is looking to bring in a new boss for its drug approval team. This person, Richard Pazdur, is known for his work in cancer treatments. If he takes the job, he'll be in charge of making sure most medicines, from those you buy without a prescription to those need

reading time less than a minute
Nov 11 2025HEALTH

Navigating Menopause: A Modern Look at Hormone Therapy

Menopause can be a challenging phase, with symptoms like hot flashes, night sweats, and sleep disturbances. Recent updates from the FDA have made hormone therapy more accessible by removing some of the previously alarming warning labels. This shift is based on new research indicating that hormone th

reading time less than a minute
Nov 11 2025HEALTH

FDA Eases Warnings on Menopause Hormone Treatments

The FDA has decided to take off the strong warning labels from hormone-based menopause treatments. These treatments help with hot flashes and night sweats. The warning labels talked about serious risks like stroke, heart attacks, and dementia. This change is based on new studies. They show that hor

reading time less than a minute
Nov 10 2025HEALTH

FDA Eases Warnings on Menopause Treatments: What You Need to Know

The FDA has made a big change. They are asking drug companies to remove the strongest warnings from menopause hormone treatments. These warnings, called "black box" warnings, alert users to serious risks. The FDA looked at lots of studies and got advice from experts before making this decision. The

reading time less than a minute
Nov 08 2025HEALTH

Semaglutide: A New Hope for Liver Health in 2025

In 2025, a significant update was made to how doctors treat a liver condition called MASH. This condition is linked to metabolic issues and used to be known as NAFLD. The update focuses on using a drug called semaglutide, which is found in a medication named Wegovy. The FDA gave Wegovy the green li

reading time less than a minute